The GIRAFE Phase II Trial on MVCT-based “Volumes of the Day” and “Dose of the Day” Addresses When and How to Implement Adaptive Radiotherapy for Locally Advanced Head and Neck Cancer
Clinical and Translational Radiation Oncology - Ireland
doi 10.1016/j.ctro.2019.02.006
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2019
Authors
Publisher
Elsevier BV